• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

Introduction to 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride (CAS No. 89218-85-9)

5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride, identified by its CAS number 89218-85-9, is a significant compound in the realm of pharmaceutical and biochemical research. This heterocyclic organic molecule, featuring a benzo[d]imidazole core, has garnered attention due to its versatile structural properties and potential applications in medicinal chemistry. The presence of chloro and chloromethyl substituents on the benzodiazole scaffold enhances its reactivity, making it a valuable intermediate in the synthesis of more complex molecules.

The benzo[d]imidazole moiety is a well-studied pharmacophore, known for its role in various biologically active compounds. Its structural framework allows for interactions with multiple biological targets, including enzymes and receptors, which has spurred extensive research into its derivatives. The specific substitution pattern in 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride imparts unique chemical properties that make it particularly useful in drug discovery efforts.

In recent years, there has been a surge in interest regarding the development of novel antiviral and anticancer agents. The benzodiazole scaffold, including derivatives like 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride, has shown promise in these areas due to its ability to modulate key cellular pathways. For instance, studies have demonstrated that certain benzo[d]imidazole derivatives can inhibit the activity of viral proteases or interfere with cancer cell proliferation by targeting specific enzymes or receptors.

The chloromethyl group in 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride serves as a versatile handle for further functionalization. This allows chemists to attach various pharmacophoric groups through nucleophilic addition reactions, enabling the synthesis of a diverse array of derivatives with tailored biological activities. Such modifications are crucial for optimizing drug candidates for clinical use, as they can enhance potency, selectivity, and pharmacokinetic properties.

Recent advancements in computational chemistry have further accelerated the discovery of novel compounds like 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride. Molecular modeling techniques, such as molecular dynamics simulations and quantum mechanical calculations, have enabled researchers to predict the binding modes of these compounds with biological targets with high accuracy. This has facilitated the rational design of derivatives with improved binding affinities and reduced off-target effects.

The hydrochloride salt form of 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride enhances its solubility in aqueous media, which is advantageous for both in vitro and in vivo studies. Improved solubility can lead to better bioavailability and more efficient drug delivery systems, which are critical factors in the development of new therapeutics.

Moreover, the synthesis of 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride involves well-established chemical methodologies that ensure high yields and purity. The reaction sequence typically involves chlorination and formylation steps on the benzodiazole precursor, followed by salt formation to stabilize the compound. These synthetic routes are scalable and compatible with industrial production standards, making 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride a practical choice for large-scale applications.

In conclusion, 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole hydrochloride (CAS No. 89218-85-9) represents a promising compound in pharmaceutical research due to its structural versatility and potential biological activities. Its utility as an intermediate in drug synthesis, coupled with recent advancements in computational chemistry and synthetic methodologies, positions it as a valuable tool for future therapeutic developments. As research continues to uncover new applications for this compound, it is likely to remain a cornerstone in the quest for innovative medicines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)